This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Nov 1;165(9):673.

doi: 10.7326/L16-0400.

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease

Robert Haussmann¹, Markus Donix¹

Affiliations

PMID: 27802468
DOI: 10.7326/L16-0400

Comment

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease

Robert Haussmann et al. Ann Intern Med. 2016.

. 2016 Nov 1;165(9):673.

doi: 10.7326/L16-0400.

Authors

Robert Haussmann¹, Markus Donix¹

Affiliation

¹ From University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.

PMID: 27802468
DOI: 10.7326/L16-0400

No abstract available

PubMed Disclaimer

Comment on

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.
Christensen KD, Roberts JS, Whitehouse PJ, Royal CD, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye GA, Uhlmann WR, Hiraki S, Wang N, Cook-Deegan R, Green RC; REVEAL Study Group*. Christensen KD, et al. Ann Intern Med. 2016 Feb 2;164(3):155-63. doi: 10.7326/M15-0187. Epub 2016 Jan 26. Ann Intern Med. 2016. PMID: 26810768 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information